BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32026666)

  • 41. Unravelling detrusor underactivity: Development of a bladder outlet resistance-Bladder contractility nomogram for adult male patients with lower urinary tract symptoms.
    Oelke M; Rademakers KL; van Koeveringe GA;
    Neurourol Urodyn; 2016 Nov; 35(8):980-986. PubMed ID: 26235823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcomes of Holmium laser enucleation of prostate and predictive model for symptom recurrence.
    Droghetti M; Porreca A; Bianchi L; Piazza P; Giampaoli M; Casablanca C; D'Agostino D; Cochetti G; Romagnoli D; Schiavina R; Brunocilla E
    Prostate; 2022 Feb; 82(2):203-209. PubMed ID: 34694647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up.
    Volpe A; Billia M; Quaglia M; Vidali M; Marchioro G; Ceratti G; Sogni F; De Lorenzis E; De Angelis P; Airoldi A; Stratta P; Terrone C
    BJU Int; 2013 Aug; 112(3):386-93. PubMed ID: 23496755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transurethral surgical treatment for benign prostatic hyperplasia with detrusor underactivity: a systematic review and meta-analysis.
    Zou P; Liu C; Zhang Y; Wei C; Liu X; Xu S; Ling Q; Chen Z; Du G; Yuan X
    Syst Rev; 2024 Mar; 13(1):93. PubMed ID: 38520009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia.
    Hur WS; Kim JC; Kim HS; Koh JS; Kim SH; Kim HW; Cho SY; Cho KJ
    Investig Clin Urol; 2016 Nov; 57(6):431-436. PubMed ID: 27847917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistent detrusor overactivity after transurethral resection of the prostate.
    Housami F; Abrams P
    Curr Urol Rep; 2008 Jul; 9(4):284-90. PubMed ID: 18765127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery.
    Jaeger CD; Krambeck AE
    Urology; 2013 May; 81(5):1025-9. PubMed ID: 23465142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
    Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
    J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urodynamic Features and Significant Predictors of Bladder Outlet Obstruction in Patients With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Small Prostate Volume.
    Kang M; Kim M; Choo MS; Paick JS; Oh SJ
    Urology; 2016 Mar; 89():96-102. PubMed ID: 26683755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event Analysis.
    Elkoushy MA; Elshal AM; Elhilali MM
    J Endourol; 2015 Jul; 29(7):797-804. PubMed ID: 25705817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI-RS 2023.
    Tarcan T; Hashim H; Malde S; Sinha S; Sahai A; Acar O; Selai C; Agro EF; Abrams P; Wein A
    Neurourol Urodyn; 2024 Aug; 43(6):1447-1457. PubMed ID: 38477358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
    Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
    World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urodynamically diagnosed detrusor hypocontractility: should transurethral resection of the prostate be contraindicated?
    Ou R; Pan C; Chen H; Wu S; Wei X; Deng X; Tang P; Xie K
    Int Urol Nephrol; 2012 Feb; 44(1):35-9. PubMed ID: 21660426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia.
    Yamanishi T; Mizuno T; Tatsumiya K; Watanabe M; Kamai T; Yoshida K
    Neurourol Urodyn; 2010 Apr; 29(4):558-62. PubMed ID: 19693954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic study.
    Matsukawa Y; Takai S; Majima T; Funahashi Y; Sassa N; Kato M; Yamamoto T; Gotoh M
    World J Urol; 2019 May; 37(5):867-872. PubMed ID: 30121825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staging of benign prostate hyperplasia is helpful in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia.
    Wang D; Foo KT
    Ann Acad Med Singap; 2010 Oct; 39(10):798-802. PubMed ID: 21063641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.